Drug developmentDerisking drug programs by early lead optimisationAntibody engineering?The development of therapeutic antibodies is a time and cost intensive process. Biological and physicochemical properties of the lead molecules influence almost every step in … more ➔
CDMONavigating the CDMO proposal processWhen businesses receive a proposal from a contract development and manufacturing organisation (CDMO), it’s much like a first date: first impressions matter. The proposal process not only reveals a CDMO’s … more ➔
Central LaboratoriesChallenges in the central labClinical trials have to be coordinated as a safe process where monitoring, analytics and handling of patient samples is streamlined – even cross oceans. German MLM Medical Labs is quickly establishing … more ➔
BiomanufacturingManufacturing Biopharmaceuticals Within the competitive CDMO market, Richter-Helm has developed into a highly valued partner when it comes to the manufacturing of biopharmaceuticals. Richter-Helm is well recognised by pharmaceutical … more ➔
BerlinInfrastructure makes the difference A well connected and effective infrastructure, a high density of research and development as well as close networking are of great value, not only to founders. Within the successful healthcare cluster … more ➔
Biobank, personalised medicinePrecision therapeutics: optimising early discovery Precision medicine tailors therapeutics to individual patients’ diseases, and is seen as the future of clinical practice. With significant time and financial investments being made in developing … more ➔
SpainSpain: An overview over a sector that has proven to be strategicAfter two years of unprecedented growth driven by the pandemic, investment attracted by Spanish biotech companies has stabilised, and they face significant challenges, positioning biotechnology as a … more ➔
Artificial intelligenceAI – tool or trouble? Depending on who you talk to, artificial intelligence (AI) is either a saviour or an enslaver. The concerns range from loss of jobs through to robots running society. However, in the life sciences, … more ➔
Novel FoodTasteful plant proteinConventional meat production contributes to 15% of the global greenhouse gas emissions, high energy consumption and land use change. Belgian Paleo NV produces alternative protein from myoglobins of different … more ➔
Sandoz, BiosimilarsBiosimilars climb the alpsGeneric and biosimilar manufacturer Sandoz is expanding with a new biologics production facility in Lendava, Slovenia to prepare for more demand in Europe for biosimilar products. more ➔
